Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05340738
Other study ID # R42MH128101
Secondary ID R42MH128101
Status Recruiting
Phase N/A
First received
Last updated
Start date March 9, 2023
Est. completion date June 30, 2025

Study information

Verified date June 2024
Source University of Pennsylvania
Contact Torrey A Creed, PhD
Phone 215-573-6773
Email tcreed@pennmedicine.upenn.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is being conducted together by researchers at the University of Pennsylvania and Lyssn.io, Inc., ("Lyssn"), a technology start-up developing digital tools to support evidence-based psychotherapies (EBPs) for mental health disorders and addiction. This study will implement a technology to assess and enhance the quality of EBPs like Cognitive Behavioral Therapy (CBT) that includes a user interface geared to clinical, supervision, and administrative workflows and needs, and then assess this technology for effectiveness in comparison to usual care. There is a tremendous global burden of mental illness: Over 50 million American adults have a diagnosable mental health disorder, and major depression on its own is the leading cause of disability worldwide. In the face of this burden, clinical research has documented a variety of effective EBPs (e.g. CBT), and these psychotherapies are utilized on a massive scale. Systems have invested over $2 billion in training providers in specific EBPs. Once trained, however, therapists' adherence to the EBP, also called fidelity, is both crucial for effectiveness and difficult to assess. There is no scalable method to assess the fidelity and quality of EBPs in community practice settings. This is a foundational problem for healthcare systems. Advances in speech processing and machine learning make technology a promising solution to this problem. The use of technology - instead of humans - to evaluate EBPs means that objective, performance-based feedback can be provided quickly, efficiently, cost-effectively, and without human error. If successful, the present research will be among the first examples of a method for building, monitoring, and assessing the quality of therapy that can scale up to large, real-world healthcare settings. In this study, the investigators will implement an existing, fully-functional prototype (LyssnCBT) that includes a user interface geared to community mental health (CMH) clinical, supervision, and administrative workflows and needs, and then assess for effectiveness of psychotherapy supported by LyssnCBT in comparison to usual care. This study will implement LyssnCBT in 5 community mental health agencies, beginning with a single-arm pilot field trial to identify and address any specific barriers to implementing the tool in a community mental health context. The study team will then conduct a larger study in community mental health agencies comparing LyssnCBT to services as usual.


Description:

The research team will first recruit 10 therapists and two supervisors from one CMH clinic in order to conduct a single-arm field trial of LyssnCBT. Each therapist will use the LyssnCBT platform with two clients over the course of two weeks (four total sessions per therapist). In addition, supervisors will conduct a supervision session with each therapist using the LyssnCBT tool's fidelity feedback. Next, participants will complete brief Likert assessments on technical reliability, functional reliability, and experiences integrating the system into the daily workflow. Usage data from LyssnCBT will be captured automatically by the system, including: which software features were used, time spent reviewing sessions and transcripts, and time spent reviewing artificial intelligence (AI) generated CBT fidelity feedback. This data and feedback will be used for a final refinement of the LyssnCBT software and related clinical and supervision protocols prior to the main trial. Following the pilot study, the research team will recruit 4 additional CMH clinics to participate in a type 2 hybrid implementation-effectiveness, randomized stepped-wedge study comparing LyssnCBT to SAU. 50 therapists and their supervisors will be recruited from the participating clinics, and each therapist will be asked to have at least 5 clients participating in the study at any given time, from among their regular caseload. Across 18 months of planned data collection (~75 weeks), the investigators expect a minimum of 1,875 clients for 50 therapists (i.e., 50 therapists x 5 sessions per week x 75 weeks = 18,750 sessions, with an average of 10 sessions per client). All 5 clinics will start with SAU, and clinics will be randomized to begin LyssnCBT sequentially over time. The primary data being collected throughout the project are recordings of therapy sessions, which are also collected as part of the typical operating procedures of the Penn Beck Community Initiative (BCI). CBT fidelity will be assessed by AI-generated Cognitive Therapy Rating Scale (CTRS) scores for every recorded therapy session, which will be recorded via the Lyssn platform during both SAU and LyssnCBT phases of the study. For client outcomes, the PHQ-9 and GAD-7 will be collected at each session and client drop-out will be assessed via a brief monthly survey sent out to participating therapists. Finally, after three months of engagement with the LyssnCBT tools, each participating therapist and supervisor will complete our battery of implementation measures, including the system usability scale, AIM, IAM, and FIM.


Recruitment information / eligibility

Status Recruiting
Enrollment 1957
Est. completion date June 30, 2025
Est. primary completion date June 30, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Therapists - Able to participate in therapy sessions conducted in English - Employed at a Philadelphia CMH treatment center that allows the recruitment and participation of therapists in research-related activities - Willing to allow their session recordings to be used for research purposes - Computer and internet access Supervisors - Oversee participating therapists - Computer and internet access Clients - Able to participate in therapy sessions conducted in English - Willing to allow the team to collect data and use their session recordings for research purposes Exclusion Criteria: - Unwilling to allow the research team to access their therapy session recordings

Study Design


Related Conditions & MeSH terms


Intervention

Other:
LyssnCBT
LyssnCBT is a technology that allows therapists and supervisors access to tools that assist with assessing CBT session fidelity, including speech-to-text transcription, annotation tools, and AI-generated metrics.

Locations

Country Name City State
United States The Penn Collaborative for CBT and Implementation Science Philadelphia Pennsylvania

Sponsors (3)

Lead Sponsor Collaborator
University of Pennsylvania Lyssn.io, Inc., National Institute of Mental Health (NIMH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in therapist CBT fidelity as assessed by CTRS scores CBT Fidelity will be assessed by AI-generated Cognitive Therapy Rating Scale (CTRS) scores for every recorded therapy session, which will be recorded via the Lyssn platform during both SAU and LyssnCBT phases of the study. CBT sessions are scored on different session components (agenda, feedback, understanding, etc.) with the CTRS on a scale of 0-6, from "poor" to "excellent", where higher scores indicate a greater degree of CBT fidelity. CTRS deviation scores will be created.Mean CTRS scores during SAU will be estimated for each therapist and for each CTRS item. These means will be subtracted from each corresponding CTRS score during the LyssnCBT phase. Phase 2; Immediately after every recorded therapy session
Primary Acceptability of LyssnCBT tools (Acceptability of Intervention Measure; AIM) A brief, 4-item measure of a mental health professional's perception of how acceptable an innovation would be for use in their context. Each statement about the acceptability of the innovation is rated on a 5-point ordinal scale ranging from "completely disagree" to "completely agree," where higher scores indicate higher levels of acceptability. This measure has demonstrated good test-retest reliability and sensitivity to change among community mental health providers. After three months of engagement with the LyssnCBT tools
Primary Appropriateness of LyssnCBT tools (Intervention Appropriateness Measure; IAM) A brief, 4-item measure of a mental health professional's perception of how appropriate an innovation would be for use in their context. Each statement about the appropriateness of the innovation is rated on a 5-point ordinal scale ranging from "completely disagree" to "completely agree," where higher scores indicate higher levels of appropriateness. This measure has demonstrated good test-retest reliability and sensitivity to change among community mental health providers. Phase 2; Three months after the site moves from SAU to LyssnCBT
Primary Feasibility of LyssnCBT tools (Feasibility of Intervention Measure; FIM) A brief, 4-item measure of a mental health professional's perception of how feasible an innovation would be for use in their context. Each statement about the feasibility of the innovation is rated on a 5-point ordinal scale ranging from "completely disagree" to "completely agree," where higher scores indicate higher levels of feasibility. This measure has demonstrated good test-retest reliability and sensitivity to change among community mental health providers. Phase 2; Three months after the site moves from SAU to LyssnCBT
Primary Usability of LyssnCBT tools (System Usability Scale; SUS) A brief, 10-item questionnaire to evaluate an end-user's perceptions of an innovation's usability. Each statement is rated on a 5-point ordinal scale ranging from "strongly disagree" to "strongly agree," with every other question reverse-coded. Scores are converted to a common scale, added together and then multiplied by 2.5 to convert the original scores to a scale of 0-100. "Average" usability is defined as a total score >68 Phase 2; Three months after the site moves from SAU to LyssnCBT
Primary Change in client depression symptoms (Patient Health Questionnaire; PHQ-9) The PHQ-9 (Patient Health Questionnaire) is a brief, widely used depression inventory assessing frequency of symptoms with 9 total items rated on a likert scale of 0-3. Higher scores indicate a greater frequency of symptoms of depression and presence of a clinically significant depressive disorder. This measure has demonstrated good test-retest reliability and can be completed within 2-3 minutes. This measure will be collected at every therapy session. Immediately before weekly therapy sessions for the duration of treatment or through study completion, a maximum of 18 months
Primary Change in client anxiety symptoms (General Anxiety Disorder; GAD-7) The GAD-7 (General Anxiety Disorder) is a brief, widely used anxiety inventory assessing frequency of symptoms with 7 total items rated on a likert scale of 0-3. Higher scores indicate a greater frequency of symptoms of anxiety and presence of a clinically significant anxiety disorder. This measure has demonstrated good test-retest reliability and can be completed within 2-3 minutes. This measure will be collected at every therapy session. Immediately before weekly therapy sessions for the duration of treatment or through study completion, a maximum of 18 months
Primary Client drop-out/premature termination from therapeutic engagement Dropout is collected via a brief monthly survey sent out to participating therapists which will ask, for each participating client, whether the client has been discharged and if that discharge was planned. Immediately before weekly therapy sessions for the duration of treatment or through study completion, a maximum of 18 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04559633 - Cognitive and Behavioral Therapy in School Refusal N/A
Completed NCT05437484 - Peer-led Brief Alcohol Intervention for College Student Drinkers in Spain N/A
Not yet recruiting NCT06013085 - Effects of Cognitive-behavioral Therapy for Insomnia in Nurses With Post Covid-19 Condition N/A
Recruiting NCT04513587 - The Effect and Applicability of CBT-Based Weight Loss Treatment Model in Obese Patients With Comorbid Depression in Health Care N/A
Completed NCT04560348 - Cognitive Behavioral Intervention and Adventure Training for Chinese University Students in Hong Kong N/A
Recruiting NCT04306835 - The Impact of CBT-i on CPAP Therapy Use and Drop Outs in OSAS Patients With Insomnia. N/A
Recruiting NCT05609916 - CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD N/A
Recruiting NCT05587127 - Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia N/A
Completed NCT04763590 - Cognitive Behavioral Therapy for Mechanical Ventilation Wean N/A
Recruiting NCT04338178 - Efficacy of a Cognitive - Affective - Addictive Based Intervention to Decrease Food Craving in Obese Patients. N/A
Active, not recruiting NCT06177223 - Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder N/A
Recruiting NCT05663034 - CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms N/A
Completed NCT05284435 - Internet-Based, Parent-Led Cognitive-Behavioral Therapy for Anxiety in Youth With ASD N/A
Completed NCT05920460 - Cognitive Behavioral Therapy for Insomnia and Depression Among Menopausal Women N/A
Recruiting NCT05616559 - Precision Medicine in the Depression Treatment
Active, not recruiting NCT04226794 - Effect of Nutritional Counseling Associated With Transcranial Direct-current Stimulation in Binge Eating Reduction Phase 2
Recruiting NCT06454695 - Improving Treatment of Major Depressive Disorder by Reducing Negative Future-Oriented Mental Imagery N/A
Completed NCT05169216 - Cognitive-Behavioral Therapy on Junior Rowers N/A
Completed NCT05329181 - Integrated Cognitive Behavioral Treatment for Substance Use and Depressive Symptoms: a Homeless Case Series N/A
Completed NCT04111874 - Parent-Led Cognitive-Behavioral Teletherapy for Anxiety in Youth With ASD N/A